Home » Posts tagged 'specialty drugs'

Tag Archives: specialty drugs

Finding an Answer to the Hepatitis C Cost Conundrum

We need to shift our treatment strategy to one that treats patients at the optimal time, thereby maximizing the treatment’s effectiveness and controlling costs for payers. (more…)

A New Line of Specialty Drugs: PCSK9 Inhibitors (Part 2)

This fall, a new line of specialty drugs will hit the market- PCSK9 inhibitors.  PCSK9 inhibitors are a new class of drugs used to lower LDL (bad) cholesterol levels through stifling a protein (PCSK9). The drug is injected once or twice a month and is (more…)

What’s a Fair Price? The Debate Over Value & Cost of Specialty Drugs (Part 1)

When Turing Pharmaceuticals raised the price of a drug that had been on the market for over 60 years from $13 to $750 a pill there was overwhelming public dismay.  For many, it highlighted the growing concern over prescription drug prices.   (more…)

Follow CESR on Facebook



Follow Schaeffer on Facebook